Latest Headlines

1. MaxCyte To Acquire Akron Bio, Expanding Its Offerings Across Cell Therapy Manufacturing And Expecting To Nearly Double Revenue Base 11/10/2026

   MaxCyte, Inc. announces that it has entered into a definitive agreement to acquire Akron BioProducts LLC (“Akron” or “Akron Bio”) from affiliates of Arcline Investment Management (“Arcline”) for total consideration of $151.8 million.

2. Elements Of A Future-Proof Sterile Fill-Finish CDMO 11/6/2026

   As the demand for biopharmaceuticals rises—especially for treating chronic conditions like arthritis and diabetes—pharmaceutical companies are increasingly turning to Contract Development and Manufacturing Organizations (CDMOs) for strategic support. The life sciences industry is under significant pressure to expand production capacity, provide patient-centered solutions, and speed up timelines.

3. Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence 11/3/2026

   Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs.

4. Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand 10/29/2026

   Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today the further expansion of its integrated bioconjugation manufacturing offering. Lonza is combining the flexibility of mid-scale bioconjugation manufacturing with its previously announced large-scale bioconjugation expansion in Visp (CH), which will now include three multiproduct suites. Together, these capabilities will offer customers a scalable manufacturing pathway from clinical development through commercial supply for antibody-drug conjugates (ADCs) and other bioconjugates.

5. Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request 10/29/2026

   Ardena has launched a searchable Biomarker Catalogue on its website, giving sponsors a faster route from biomarker selection to a bioanalysis quote.

6. Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus 10/23/2026

   Meissner Corporation, a leading manufacturer of advanced microfiltration and therapeutic manufacturing systems for biopharmaceutical production of life-saving and life enhancing medicines, celebrated a double milestone in Athens-Clarke County: the ribbon cutting for its new X-ray irradiation services facility and the groundbreaking for Phase 2 of its Athens, Georgia, U.S.A., manufacturing campus.

7. Zylidac Bio And Prolific Machines Partner To Scale Prolific's Next-Generation Biologics Manufacturing Platform To GMP Production 10/21/2026

   Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, today announced a partnership to scale Prolific’s platform from early development through GMP production.

8. Revvity Launches Signals LabGistics Solution To Connect And Orchestrate Scientific Workflows 10/21/2026

   Revvity, Inc. (NYSE: RVTY), announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

9. All-In-One Solution For Continuous Microbial Monitoring Without Production Interruptions 10/20/2026
10. Kindeva Awarded Up To $226 Million Contract To Supply ATNAA Autoinjectors To The Defense Logistics Agency 10/16/2026